ReThink Pharmaceuticals Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $5K
Latest Deal Amount
  • Investors
  • 1

ReThink Pharmaceuticals General Information


Owner and operator of a biotechnology company. The company works in the field of drug re-purposing by developing a distinct algorithm based on evolutionary genomics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Drug Delivery
Primary Office
  • Aluf Kalman Magen 3
  • Tel Aviv 6107075
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ReThink Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 24-Jun-2015 $5K 000 Completed Startup
To view ReThink Pharmaceuticals’s complete valuation and funding history, request access »

ReThink Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Etty Amir Ph.D Co-Founder & Chief Executive Officer
Guy Seemann Co-Founder & Chief Operating Officer
Yuval Tabach Co-Founder & Chief Scientist
Dmitry Shvartsman Ph.D Co-Founder & Scientific Adviser
To view ReThink Pharmaceuticals’s complete executive team members history, request access »

ReThink Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
To view ReThink Pharmaceuticals’s complete investors history, request access »